ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to ACHC. ACHC was compared to 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
In multiple years ACHC reported negative net income over the last 5 years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 3.05%, ACHC is doing good in the industry, outperforming 64.08% of the companies in the same industry.
ACHC has a Return On Equity of 6.17%. This is in the better half of the industry: ACHC outperforms 65.05% of its industry peers.
With a decent Return On Invested Capital value of 6.43%, ACHC is doing good in the industry, outperforming 66.02% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROIC | 6.43% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
ACHC has a Profit Margin of 5.94%. This is amongst the best in the industry. ACHC outperforms 82.52% of its industry peers.
In the last couple of years the Profit Margin of ACHC has grown nicely.
Looking at the Operating Margin, with a value of 14.95%, ACHC belongs to the top of the industry, outperforming 87.38% of the companies in the same industry.
ACHC's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACHC is destroying value.
Compared to 1 year ago, ACHC has more shares outstanding
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
Compared to 1 year ago, ACHC has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.31, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACHC (1.31) is worse than 67.96% of its industry peers.
A Debt/Equity ratio of 0.72 indicates that ACHC is somewhat dependend on debt financing.
ACHC's Debt to Equity ratio of 0.72 is in line compared to the rest of the industry. ACHC outperforms 48.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.31 |
ROIC/WACC0.78
WACC8.28%
2.3 Liquidity
ACHC has a Current Ratio of 1.35. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Current ratio of 1.35. This is comparable to the rest of the industry: ACHC outperforms 42.72% of its industry peers.
A Quick Ratio of 1.34 indicates that ACHC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.34, ACHC is in line with its industry, outperforming 49.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
The earnings per share for ACHC have decreased strongly by -18.75% in the last year.
ACHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.21% yearly.
The Revenue has been growing slightly by 5.48% in the past year.
Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 9.45% on average per year.
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
3.2 Future
The Earnings Per Share is expected to grow by 5.66% on average over the next years.
Based on estimates for the next years, ACHC will show a quite strong growth in Revenue. The Revenue will grow by 8.46% on average per year.
EPS Next Y-18.74%
EPS Next 2Y-4.79%
EPS Next 3Y-0.83%
EPS Next 5Y5.66%
Revenue Next Year5.56%
Revenue Next 2Y7.05%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.43, the valuation of ACHC can be described as reasonable.
Based on the Price/Earnings ratio, ACHC is valued cheaper than 95.15% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. ACHC is valued rather cheaply when compared to this.
ACHC is valuated reasonably with a Price/Forward Earnings ratio of 8.06.
ACHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 93.20% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACHC to the average of the S&P500 Index (21.76), we can say ACHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.43 | ||
| Fwd PE | 8.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACHC is valued cheaper than 84.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
The decent profitability rating of ACHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.83
EPS Next 2Y-4.79%
EPS Next 3Y-0.83%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.12
+0.8 (+3.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners110.43%
Inst Owner Change0%
Ins Owners1.39%
Ins Owner Change8.3%
Market Cap2.22B
Analysts82
Price Target43.71 (81.22%)
Short Float %10.27%
Short Ratio3.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.13%
Min EPS beat(2)-12.21%
Max EPS beat(2)9.95%
EPS beat(4)2
Avg EPS beat(4)-0.27%
Min EPS beat(4)-12.21%
Max EPS beat(4)9.95%
EPS beat(8)6
Avg EPS beat(8)1.47%
EPS beat(12)9
Avg EPS beat(12)9.78%
EPS beat(16)11
Avg EPS beat(16)7.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.51%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.8%
PT rev (1m)-7.6%
PT rev (3m)-9.7%
EPS NQ rev (1m)0.49%
EPS NQ rev (3m)-9.6%
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.43 | ||
| Fwd PE | 8.06 | ||
| P/S | 0.7 | ||
| P/FCF | N/A | ||
| P/OCF | 4.8 | ||
| P/B | 0.73 | ||
| P/tB | 3.24 | ||
| EV/EBITDA | 6.85 |
EPS(TTM)2.86
EY11.86%
EPS(NY)2.99
Fwd EY12.4%
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)5.02
OCFY20.81%
SpS34.26
BVpS33.02
TBVpS7.45
PEG (NY)N/A
PEG (5Y)0.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 6.17% | ||
| ROCE | 8.32% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.54% | ||
| ROICexgc | 11.31% | ||
| OM | 14.95% | ||
| PM (TTM) | 5.94% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 450.84% | ||
| Cap/Sales | 22.89% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.31 |
F-Score6
WACC8.28%
ROIC/WACC0.78
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.75%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-52.38%
EPS Next Y-18.74%
EPS Next 2Y-4.79%
EPS Next 3Y-0.83%
EPS Next 5Y5.66%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%0.32%
Revenue Next Year5.56%
Revenue Next 2Y7.05%
Revenue Next 3Y7.15%
Revenue Next 5Y8.46%
EBIT growth 1Y-9.84%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year22.45%
EBIT Next 3Y13.59%
EBIT Next 5Y11.46%
FCF growth 1Y-820.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.81%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%